Rule 18, Drugs (Prices Control) Order, 2013: Revision of ceiling price on the basis of moving annual turnover (MAT)
Drugs (Prices Control) Order, 2013 - Rule 18
Text of rule 18
Revision of ceiling price on the basis of moving annual turnover (MAT)
18. Revision of ceiling price on the basis of moving annual
turnover (MAT).– The revision of ceiling prices on the basis of
moving annual turnover value shall be carried out,-
(i) as and when the National List of Essential Medicines is revised by
the Ministry of Health and Family Welfare or five years from the date
of fixing the ceiling price under this Order whichever is earlier;
(ii) when the number of manufacturers of a scheduled formulation,
having price of a scheduled formulation more than or equal to
seventy five percent of the ceiling price fixed and notified by the
Government, has decreased by twenty five percent or more than the
number of manufacturers as existing on the reference date;
(iii) when the number of manufacturers of a scheduled formulation,
having prices of their scheduled formulation equal to or lower than
twenty five percent of the ceiling price fixed by the Government, has
increased by twenty five percent or more than the number of
manufacturers as existing on the reference date.
Explanation.- For the purpose of items (ii) and (iii) the “reference
date” shall be for first revision of ceiling price May, 2012 and for
second or subsequent revision the date of previous revision of the
ceiling price.
Previous and next
Questions people ask
Is rule 18 of Drugs (Prices Control) Order, 2013 still in force?
No repeal of Drugs (Prices Control) Order, 2013 is recorded.